Design of artificial α-helical peptides targeting both gp41 deep pocket and subpocket as potent HIV-1 fusion inhibitors

This publication has 37 references indexed in Scilit:

• Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621–652
  Journal of Biological Chemistry, 2012
• Stable Extended Human Immunodeficiency Virus Type 1 gp41 Coiled Coil as an Effective Target in an Assay for High-Affinity Fusion Inhibitors
  Antimicrobial Agents and Chemotherapy, 2009
• Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
  Proceedings of the National Academy of Sciences, 2009
• Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives as Potent HIV Fusion Inhibitors Targeting gp41
  Journal of Medicinal Chemistry, 2008
• Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains
  Proceedings of the National Academy of Sciences, 2008
• Rationally Designed Anti-HIV Peptides Containing Multifunctional Domains as Molecule Probes for Studying the Mechanisms of Action of the First and Second Generation HIV Fusion Inhibitors
  Journal of Biological Chemistry, 2008
• Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs
  Biochemical and Biophysical Research Communications, 2008
• Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus
  Proceedings of the National Academy of Sciences, 2007
• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
  Proceedings of the National Academy of Sciences, 1994
• Helix propensities of the amino acids measured in alanine‐based peptides without helix‐stabilizing side‐chain interactions
  Protein Science, 1994